The cost of production in cervical cytology

Comparison of conventional and automated primary screening systems

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To thrive in a world of managed care and capitation, knowing the cost of production is critical, especially in cervical cytology. The relative costs of production for preparation and interpretation of cervical cytology for conventional manually read smears and a primary automated screening method were calculated in a university practice setting. The components were disposables, processing, screening, pathologist review, capital equipment, and facilities cost. The production cost for a conventional smear in our laboratory is $9.75, and the comparable production cost by a primary screening automated method would be $12.07, if it were approved for primary screening. Based on these calculations, an interactive automated method approved for primary screening would cost slightly more than conventional testing. Combinations of conventional and automated examinations (secondary screening systems) are not cost feasible unless the additional production expense can be passed through to the payers.

Original languageEnglish (US)
Pages (from-to)445-450
Number of pages6
JournalAmerican Journal of Clinical Pathology
Volume107
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

Cell Biology
Costs and Cost Analysis
Managed Care Programs
Economics

Keywords

  • Automated cytoscreening
  • Gynecologic cytology
  • Papanicolaou

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{3094ede4bf8f452e88ec7217b2ca832b,
title = "The cost of production in cervical cytology: Comparison of conventional and automated primary screening systems",
abstract = "To thrive in a world of managed care and capitation, knowing the cost of production is critical, especially in cervical cytology. The relative costs of production for preparation and interpretation of cervical cytology for conventional manually read smears and a primary automated screening method were calculated in a university practice setting. The components were disposables, processing, screening, pathologist review, capital equipment, and facilities cost. The production cost for a conventional smear in our laboratory is $9.75, and the comparable production cost by a primary screening automated method would be $12.07, if it were approved for primary screening. Based on these calculations, an interactive automated method approved for primary screening would cost slightly more than conventional testing. Combinations of conventional and automated examinations (secondary screening systems) are not cost feasible unless the additional production expense can be passed through to the payers.",
keywords = "Automated cytoscreening, Gynecologic cytology, Papanicolaou",
author = "Bishop, {John W}",
year = "1997",
language = "English (US)",
volume = "107",
pages = "445--450",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - The cost of production in cervical cytology

T2 - Comparison of conventional and automated primary screening systems

AU - Bishop, John W

PY - 1997

Y1 - 1997

N2 - To thrive in a world of managed care and capitation, knowing the cost of production is critical, especially in cervical cytology. The relative costs of production for preparation and interpretation of cervical cytology for conventional manually read smears and a primary automated screening method were calculated in a university practice setting. The components were disposables, processing, screening, pathologist review, capital equipment, and facilities cost. The production cost for a conventional smear in our laboratory is $9.75, and the comparable production cost by a primary screening automated method would be $12.07, if it were approved for primary screening. Based on these calculations, an interactive automated method approved for primary screening would cost slightly more than conventional testing. Combinations of conventional and automated examinations (secondary screening systems) are not cost feasible unless the additional production expense can be passed through to the payers.

AB - To thrive in a world of managed care and capitation, knowing the cost of production is critical, especially in cervical cytology. The relative costs of production for preparation and interpretation of cervical cytology for conventional manually read smears and a primary automated screening method were calculated in a university practice setting. The components were disposables, processing, screening, pathologist review, capital equipment, and facilities cost. The production cost for a conventional smear in our laboratory is $9.75, and the comparable production cost by a primary screening automated method would be $12.07, if it were approved for primary screening. Based on these calculations, an interactive automated method approved for primary screening would cost slightly more than conventional testing. Combinations of conventional and automated examinations (secondary screening systems) are not cost feasible unless the additional production expense can be passed through to the payers.

KW - Automated cytoscreening

KW - Gynecologic cytology

KW - Papanicolaou

UR - http://www.scopus.com/inward/record.url?scp=0030988576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030988576&partnerID=8YFLogxK

M3 - Article

VL - 107

SP - 445

EP - 450

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -